What is KeyCorp’s Forecast for SLP Q1 Earnings?

Simulations Plus, Inc. (NASDAQ:SLP) – Equities researchers at KeyCorp issued their Q1 2026 earnings estimates for Simulations Plus in a report issued on Monday, July 14th. KeyCorp analyst S. Schoenhaus forecasts that the technology company will post earnings per share of $0.19 for the quarter. KeyCorp currently has a “Sector Weight” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.09 per share. KeyCorp also issued estimates for Simulations Plus’ Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.23 EPS and FY2027 earnings at $0.96 EPS.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 10.65%. The business had revenue of $20.36 million for the quarter, compared to analysts’ expectations of $22.83 million. During the same period in the previous year, the company posted $0.27 EPS. Simulations Plus’s revenue was up 9.8% on a year-over-year basis.

A number of other brokerages have also commented on SLP. JMP Securities reaffirmed a “market perform” rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Craig Hallum cut their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, June 13th. Stephens cut their price objective on shares of Simulations Plus from $28.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday. Wall Street Zen raised shares of Simulations Plus from a “sell” rating to a “hold” rating in a research report on Monday, April 28th. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Simulations Plus has an average rating of “Moderate Buy” and a consensus target price of $26.50.

Simulations Plus Price Performance

Simulations Plus stock opened at $12.91 on Wednesday. The firm has a market cap of $259.62 million, a price-to-earnings ratio of -4.10 and a beta of 0.83. Simulations Plus has a fifty-two week low of $12.85 and a fifty-two week high of $44.27. The firm has a fifty day moving average price of $23.80 and a two-hundred day moving average price of $28.08.

Institutional Investors Weigh In On Simulations Plus

Several hedge funds have recently bought and sold shares of SLP. Jones Financial Companies Lllp raised its holdings in shares of Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after acquiring an additional 427 shares during the period. Johnson Financial Group Inc. bought a new position in Simulations Plus in the fourth quarter valued at $39,000. Fifth Third Bancorp grew its position in Simulations Plus by 33.8% in the first quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company’s stock valued at $36,000 after purchasing an additional 375 shares in the last quarter. Tower Research Capital LLC TRC grew its position in Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after purchasing an additional 764 shares in the last quarter. Finally, AlphaQuest LLC grew its position in Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the transaction, the director directly owned 3,344,157 shares of the company’s stock, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.